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Background and aims: Gambling disorder (GD) may have its onset in a wide range of ages, from adolescents to old
adults. In addition, individuals with GD tend to seek treatment at different moments in their lives. As a result of these
characteristics (variable age at onset and variable age at treatment seeking), we ﬁnd subjects with diverse duration of
illness (DOI) in clinical practice. DOI is an important but relatively understudied factor in GD. Our objective was to
investigate clinical and neurocognitive characteristics associated with different DOI. Methods: This study evaluated
448 adults diagnosed with GD. All assessments were completed prior to treatments being commenced. Results: Our
main results were: (a) there is a negative correlation between DOI and lag between ﬁrst gambling and onset of GD; (b)
lifetime history of alcohol use disorder (AUD) is associated with a longer duration of GD; (c) the presence of a ﬁrst-
degree relative with history of AUD is associated with a more extended course of GD; and (d) there is a negative
correlation between DOI and quality of life. Discussion: This study suggests that some important variables are
associated with different DOI. Increasing treatment-seeking behavior, providing customized psychological inter-
ventions, and effectively managing AUD may decrease the high levels of chronicity in GD. Furthermore, research on
GD such as phenomenological studies and clinical trials may consider the duration of GD in their methodology. DOI
might be an important variable when analyzing treatment outcome and avoiding confounders.
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INTRODUCTION
Gambling disorder (GD) affects a signiﬁcant number of
people; for example, up to 3.24 million people have devel-
oped GD at some point of their lives in the United States
alone (United States Census Bureau, 2016). The disorder is
associated with several negative consequences, such as high
rates of psychiatric comorbidity and suicidality, frequent
legal and occupational problems as well as with lower levels
of quality of life (Black, Moyer, & Schlosser, 2003; Grant &
Kim, 2005; Petry & Kiluk, 2002; Petry, Stinson, & Grant,
2005). GD poses a considerable economic burden, estimated
at $5 billion every year in the United States alone (National
Gambling Impact Study Commission, United States of
America, 1999). GD is a clinically heterogeneous disorder
and different subgroups of affected subjects have been
examined (Ledgerwood & Petry, 2006; Ledgerwood,
Weinstock, Morasco, & Petry, 2007). A deeper understand-
ing of the subtypes of GD may lead to customized, more
effective treatments. This is particularly important given that
GD tends to demonstrate high chronicity and relapse rates
(American Psychiatric Association, 2013; Blanco, Moreyra,
Nunes, Saiz-Ruiz, & Ibanez, 2001; Potenza, 2001).
One important but relatively understudied factor in GD is
the duration of illness (DOI). For instance, GD may have its
onset in a wide range of ages, from adolescents to old adults
(American Psychiatric Association, 2013; Burge, Pietrzak,
Molina, & Petry, 2004; Kessler et al., 2008; Ladd, Molina,
Kerins, & Petry, 2003; Lynch, Maciejewski, & Potenza,
2004; Medeiros et al., 2015; Shaffer, Hall, & Vander Bilt,
1999). In addition, individuals with GD tend to seek treat-
ment at different moments in their lives (Petry, 2002). As a
result of these characteristics (variable age at onset and
variable age at treatment seeking), we ﬁnd patients with
diverse DOI in clinical practice.
Studies with other addictions (substance-associated and
other behavioral addictions) have shown the importance of
DOI in the clinical presentation of the disorders. In the case
of alcohol and other substance use disorders, studies have
suggested that longer duration of alcohol use disorder
(AUD), methamphetamine use disorder, and heroin use are
correlated with more cognitive deﬁcits. This is particularly
true for response inhibition, reaction time, and cognitive
ﬂexibility (Laloyaux et al., 2012; Martinovic-Mitrovic et al.,
2008; Monterosso, Aron, Cordova, Xu, & London, 2005).
Moreover, research in AUD suggested that early onset of
problems with alcohol is associated with stronger genetic
susceptibility and poorer treatment outcome (Babor et al.,
1992; Carpenter & Hasin, 2001; Cloninger, 1987; Schuckit
et al., 1995). These two elements (genetic vulnerability and
worse prognosis) may lead to longer DOI. With regard to
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behavioral addictions, Mathy and Cooper (2003) found that
longer duration of exposure to the Internet was associated
with negative outcomes in a non-clinical sample of Internet
users. Regarding GD, Tsurumi et al. (2014) found a negative
correlation between DOI and insula activation, a neurologi-
cal area associated with reward anticipation and risk evalu-
ation (Damasio, 1994; Kuhnen & Knutson, 2005; Xue, Lu,
Levin, & Bechara, 2010). These ﬁndings suggest the need
for further clinical and neurocognitive investigations of the
inﬂuence of DOI in GD. Although DOI seems to be an
important variable in understanding GD, no study, to our
knowledge, has speciﬁcally investigated how this variable
might affect the clinical presentation of the disorder.
Our objective was to investigate clinical and neurocog-
nitive characteristics associated with different DOI in a
sample of adults with GD. It was anticipated that this study
would provide insights regarding how future work might
improve treatments for patients. Our main hypotheses were
that a longer DOI would be signiﬁcantly associated with:
(a) worse clinical outcomes such as more ﬁnancial losses,
worse severity of GD, and reduced quality of life; (b) a
stronger genetic vulnerability clinically evidenced by per-
sonal history of AUD and family history of GD and AUD;
and (c) worse neurocognitive deﬁcits, especially in response
inhibition and cognitive ﬂexibility.
METHODS
Participants
This study evaluated 448 adults diagnosed with GD. In all,
197 (44.0%) individuals were males and 251 individuals
(56.0%) were females. The mean and median age of our
sample were 47.6 (±11.3) and 49.0 years, respectively. The
studied sample consisted of individuals who participated in
clinical trials on GD (pharmacotherapy or cognitive behav-
ioral therapy) at the University of Minnesota and at the
University of Chicago. The subjects were recruited by
media advertisements (public places, Internet, and news-
papers). All assessments were completed prior to treatments
being commenced.
The inclusion criteria were: (a) age ≥18 years, (b) current
GD diagnosis, and (c) able to attend the clinical center for
assessment. This research excluded subjects who: (a) need-
ed emergency care or presented unstable medical illness;
(b) showed clinically signiﬁcant abnormalities on physical
examination; (c) were unable to complete the study proce-
dures; (d) demonstrated psychotic symptoms; and (e) did not
provide written consent to participate in the study.
All studied individuals underwent a semi-structured clini-
cal interview conducted by a board-certiﬁed and research-
trained psychiatrist. Individuals were ﬁnancially compensated
(gift cards to local stores) for their participation in this study.
Measures
GD diagnosis. The diagnosis of GD was performed using
the Structured Clinical Interview for Pathological Gam-
bling. This diagnostic instrument was originally developed
and validated using the criteria of the fourth edition of the
Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) (Grant, Steinberg, Kim, Rounsaville, & Potenza,
2004). As the data collected before the release of DSM-5
were electronically saved, the authors retrospectively pro-
cessed them for a proper adaptation to DSM-5 GD criteria.
This approach consisted of removing the criterion “com-
mitted illegal acts such as forgery, fraud, theft, or embez-
zlement to ﬁnance gambling regarding illegal acts,” which
was present in previous manual, DSM-IV. Moreover, we
reduced the diagnostic threshold from ﬁve to four criteria,
consistent with DSM-5. The remaining criteria were
unchanged.
During the diagnostic interview, we also evaluated [age
at ﬁrst gambling] and [age at onset of GD]. The trained
board-certiﬁed psychiatrists conducted all diagnostic
interviews.
DOI. DOI was deﬁned as the difference between age at
intake and age when full criteria for GD met.
Demographics. Age at intake, gender, marital status,
educational status, and ethnicity were obtained from the
participants.
Gambling behavior.
– Age at ﬁrst gambling and progression from recrea-
tional gambling to GD (lag between ﬁrst gambling and
onset of GD): this variable was calculated as the differ-
ence between [age at onset of GD] and [age at ﬁrst
gambling] (collected in the diagnostic interview – see
GD Diagnosis subsection).
– Gambling frequency: it is assessed by how many days
per week the subject gambled.
– Primary form of gambling: the participants were asked
to specify the main form of gambling based on money
spent, frequency, and negative consequences. We
grouped the form of betting in strategic (sports betting,
cards, dice, stock markets, etc.) and non-strategic meth-
ods (slot machines, pull tabs, lottery, video poker, etc.)
(Grant, Odlaug, Chamberlain, et al., 2012).
– Monetary losses: we assessed money lost due to
gambling in the last year (in American dollars) and
income in the last year (in American dollars). The
coefﬁcient of money lost/income provided the percent-
age of income lost in gambling (last year).
– Severity of GD: we evaluated GD severity using the
Gambling Symptom Assessment Scale (G-SAS) and the
Yale–Brown Obsessive-Compulsive Scale modiﬁed for
Pathological Gambling (PG-YBOCS). The G-SAS is a
valid and reliable 12-item scale that investigates gambling
symptoms in the past week (Kim, Grant, Potenza, Blanco,
& Hollander, 2009). The PG-YBOCS is a 10-item ques-
tionnaire that has demonstrated high validity (r= .895) and
reliability (Cronbach’s α= .970) (Pallanti, DeCaria, Grant,
Urpe, & Hollander, 2005). The PG-YBOCS provides an
overall score as well as scores in two subscales: (a) urge
subscale and (b) behavior subscale.
Psychiatric symptoms/antecedents and quality of life.
– Lifetime prevalence of co-occurring psychiatric dis-
orders: the subjects were assessed for co-occurring
psychiatric disorders by two validated semi-structured
interviews: the Mini-International Neuropsychiatric
Interview (M.I.N.I.) and the Minnesota Impulsive Dis-
orders Interview (M.I.D.I.). The M.I.N.I. evaluates the
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lifetime existence of main co-occurring psychiatric dis-
order comorbidities (Sheehan et al., 1998), whereas the
M.I.D.I. assesses impulsive/compulsive behaviors
(Odlaug & Grant, 2010).
– Current depressive and anxiety symptoms: the Hamil-
ton Anxiety Rating Scale (HAM-A) is a valid and reliable
14-item questionnaire that evaluates the severity of anxi-
ety symptoms in the past week (Beck & Steer, 1991;
Hamilton, 1969; Maier, Buller, Philipp, & Heuser, 1988;
Snaith, Baugh, Clayden, Husain, & Sipple, 1982).
– Previous treatment for GD: the subjects were asked
(self-report measure) if they had sought previous treat-
ment speciﬁcally for GD. Individual outpatient treatment,
group outpatient treatment, and inpatient treatment were
considered formalized treatments.
– Family history of GD and AUD: the family history of
AUD was evaluated as a self-report measure from the
subject. They were asked if they had a ﬁrst-degree
relative with GD or AUD.
– Quality of life: it is investigated by the Quality of Life
Inventory (QOLI), which is a 17-item questionnaire that
assesses the subjects’ overall quality of life (Frisch et al.,
1992).
Neurocognitive measures. the participants undertook two
selected tests from the computerized Cambridge Neuropsy-
chological Test Automated Battery (CANTABeclipse,
version 3, Cambridge Cognition Ltd., Cambridge, UK;
Cambridge Cognition, 2015).
– Response inhibition: it is evaluated by the stop-signal
task. This assessment measures the participant’s ability to
suppress/inhibit motor responses. The subjects react to an
arrow stimulus, by pressing either a left or right key
depending on the position of the arrow. When an audi-
tory stimulus occurs, the individual attempts to inhibit
their motor response for the particular trial (Morein-
Zamir & Sahakian, 2010). The measurement of the
response inhibition is the stop-signal reaction time, a
score that evaluates the time taken for the participant’s
brain to suppress a response that would normally be
performed.
– Cognitive ﬂexibility: it is evaluated by the intra-/extra-
dimensional set shifting test. This task assessed rule
learning, reversal, and changing of attentional focus. The
trial provides visual stimuli (white lines and colorful
shapes) and feedback to the subjects in a way that they
can learn an underlying “rule” regarding which stimulus
is correct, based on trial and error. The underlining rule
that controls what is “correct” and “incorrect” shifts
several times and evaluates the individual’s capacity to
respond with cognitive ﬂexibility (Cambridge Cognition,
2015). The overall performance is assessed by adjusted
total number of errors.
Statistical analysis
First, we conducted a one-sample Kolmogorov–Smirnov
test to evaluate the distribution of the continuous
variables. As all continuous variables showed a non-
parametric dispersal, we evaluated the association be-
tween DOI and the clinical/neurocognitive variables
using Spearman’s rank correlation coefﬁcient and
Mann–Whitney U test, respectively, for continuous and
categorical variables. To investigate which variables ulti-
mately affected DOI, we performed multiple linear regres-
sions. In this procedure, we introduced the clinical variables
with level of signiﬁcance (sig.) <.01. Additional controlled
analyses assessing DOI and continuous variables were
conducted using partial correlation coefﬁcients.
Ethics
This research was approved by the Institutional Review
Boards of the University of Chicago and University of
Minnesota. The research procedures were described to the
participants prior to providing consent. The investigators
provided time for the subjects to ask questions. All indivi-
duals provided written informed consent for participation.
The study procedures followed the rules of the World
Medical Association Declaration of Helsinki, which de-
scribe ethical principles for medical research involving
human subjects (World Medical Association, 2002).
RESULTS
The mean and median DOI in our sample were 10.2 (±7.7)
and 8.0 years, respectively. This variable showed a right-
skewed distribution (see Figure 1).
In terms of severity, the participants demonstrated a
mean G-SAS total score of 34.6 (±12.5), therefore in the
severe range (from 31 to 40 points) (Kim et al., 2009).
Table 1 describes the main demographic and clinical vari-
ables in our sample.
Regarding gambling behavior, we found a statistically
signiﬁcant negative correlation between DOI and lag
between ﬁrst gambling and onset of GD. A longer DOI
was not associated with higher severity scores in G-SAS
or PG-YBOCS. Table 2 displays the association between
DOI and gambling behavior variables.
With respect to psychiatric antecedents and quality of
life, a longer DOI was signiﬁcantly associated with per-
sonal history of AUD and the presence of a ﬁrst-degree
relative with history of AUD. In addition, DOI presented a
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Figure 1. Distribution of duration of illnessa in treatment-seeking
subjects with gambling disorder (n= 448). aDuration of illness was
deﬁned as the difference between [current age] and [age at onset of
gambling disorder]
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Table 1. Description of demographics and main clinical variables in treatment-seeking adults with
gambling disorder (n= 448)
Variables
Mean (SDa)/median
or % (n)
Demographics
Age 47.6 (±11.3)/49.0
Gender
Male 44.0 (197)
Female 56.0 (251)
Marital status
With partner 36.7 (173)
Without partner 63.3 (275)
Educational level
Less than college 36.7 (164)
College or more 63.3 (283)
Ethnicity
Caucasian 89.2 (397)
Non-Caucasian 10.8 (48)
Clinical variables
Duration of illnessb 10.2 (±7.7)/8.0
Age at ﬁrst gambling 28.1 (±13.2)/25.0
Age at onset of gambling disorder 37.4 (±12.2)/37.0
Frequency of gambling (times a week) [Nc= 365] 6.6 (±9.4)/2.5
G-SASd total score [N= 382] 34.6 (±12.5)/33.0
PG-YBOCSe total score [N= 290] 20.8 (±5.4)/20.0
Previous formalized treatmentf for gambling disorder [N= 365] 18.6 (68)
Previous gamblers anonymous treatment [N= 365] 39.7 (145)
Lifetime prevalence of any affective disorder 27.2 (122)
Lifetime prevalence of any anxiety disorder 12.3 (55)
Lifetime prevalence of alcohol use disorder 23.2 (104)
Lifetime prevalence of substance use disorder 11.7 (52)
Note. %: relative values; n: absolute values.
aStandard deviation. bDuration of illness was deﬁned as the difference between [age at intake] and [age at
onset of gambling disorder]. cNumber of valid subjects for the variable. If N is not displayed, the total
sample (n= 448) was evaluated for the variable. dThe Gambling Symptom Assessment Scale (Kim et al.,
2009). eYale–Brown Obsessive-Compulsive Scale modiﬁed for Pathological Gambling (Pallanti et al.,
2005). fFormalized treatment: individual outpatient treatment and/or group outpatient treatment and/or
inpatient treatment.
Table 2. Association between gambling behavior and duration of illnessa (DOI) in treatment-seeking adults with
gambling disorder (n= 448)
Gambling behavior variables
Correlation coefﬁcientb
or mean DOI (SDc) p value
Lag between ﬁrst gambling and onset of gambling disorder −0.094 .049
Gambling frequency (times a week) [Nd= 365] 0.030 .563
Primary form of gambling (strategic/non-strategic) 10.8 (±8.1)/9.9 (±7.0) .524
Percentage of income lost in gambling (last year) −0.096 .088
G-SASe total score [N= 382] −0.082 .108
PG-YBOCSf total score [N= 290] 0.057 .332
PG-YBOCS urge subscale [N= 290] −0.019 .745
PG-YBOCS gambling behavior subscale [N= 290] 0.112 .056
Note. p values with statistically signiﬁcant differences (p< .05) are highlighted in bold.
aDuration of illness was deﬁned as the difference between [age at intake] and [age at onset of gambling disorder].
bSpearman’s rank correlation coefﬁcient. cStandard deviation. dNumber of valid subjects for the variable. If N is
not displayed, the total sample (n = 448) was evaluated for the variable. eThe Gambling Symptom Assessment
Scale (Kim et al., 2009). fYale–Brown Obsessive-Compulsive Scale modiﬁed for Pathological Gambling
(Pallanti et al., 2005).
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negative correlation with quality of life. These results are
displayed in Table 3.
Finally, we conducted multiple linear regressions where
we introduced the clinical variables with level of sig. <.05 in
the univariate analysis. The variables inserted in this model
were: [lag between ﬁrst gambling and onset of GD], [lifetime
prevalence of AUD], [ﬁrst-degree relative with history of
AUD], and [quality of life (QOLI)]. The model did not reach
statistical signiﬁcance. Final model = [QOLI] (B =−.077;
95% conﬁdence interval for B = lower limit: −.165, upper
limit: .010; constant: B = 13.069; sig.< .001); model sum-
mary: R = .154; R2 = .024; degrees of freedom = 4; sig.
= .084. Strategy used = backward. Therefore, the multivari-
ate approach was not more informative than the conclusions
withdrawn from the univariate analysis.
DISCUSSION
This research evaluated the association between DOI,
clinical, and neurocognitive variables in a sample of 448
adult subjects with GD. This is, to our knowledge, the ﬁrst
study to investigate speciﬁcally DOI in GD. We assessed
gambling behavior, psychiatric antecedents, quality of life,
and neurocognitive variables. Our main results were:
(a) there is a negative correlation between DOI and lag
between ﬁrst gambling and onset of GD; (b) lifetime
history of AUD is associated with a longer duration of
GD; (c) the presence of a ﬁrst-degree relative with history
of AUD is associated with a more extended course of GD;
and (d) there is a negative correlation between DOI and
quality of life.
DOI, GD severity, and ﬁnancial losses
Contrary to our initial hypothesis, no associations were seen
between DOI and GD severity in this study. Neither we were
able to ﬁnd signiﬁcant correlations between DOI and ﬁnan-
cial losses (evaluated by percentage of income lost last
year). It is important to notice that, although a longer DOI
was not signiﬁcantly associated with greater ﬁnancial losses
in the past year, more extended DOI tends to be correlated
with higher lifetime losses. This is a result of recurrent
losses and expenses in bets throughout the years. The money
spent in gambling could be invested in healthier, self-
fulﬁlling, and productive ways. Chronic monetary losses
may also explain in part why subjects with long-duration
GD report a lower quality of life (see more in DOI and
Quality of Life subsection).
The absence of a cross-sectional correlation between
DOI and GD severity in treatment-seeking/clinical trial
samples may be due to a possible selection bias (i.e.,
individuals with chronic GD may be less prone to seek
treatment or participate in clinical trials). Future studies
assessing the association between duration of GD and
severity of symptoms in non-clinical samples are needed.
DOI and lag between ﬁrst gambling and GD
This study found a negative correlation between DOI and
lag between ﬁrst gambling and onset of GD. Previous
studies have suggested that women tend to have a faster
progression from recreational gambling to GD when
compared with men (Grant, Odlaug, & Mooney, 2012;
Ibán˜ez, Blanco, Moreryra, & Sáiz-Ruiz, 2003; Tavares
Table 3. Association between duration of illnessa (DOI), psychiatric antecedents, quality of life, and neurocognitive variables in treatment-
seeking subjects with gambling disorder (n= 448)
Variables Mean DOI (SDb) or correlation coefﬁcientc p value
Psychiatric antecedents and quality of life
Lifetime prevalence of any affective disorder (yes/no) 10.2 (±7.5)/10.3 (±7.8) .820d
Depressive symptoms (Hamilton Depression Rating Scale) −0.063 .182
Lifetime prevalence of any anxiety disorder (yes/no) 8.0 (±5.7)/10.5 (±7.9) .059d
Anxiety symptoms (Hamilton Anxiety Rating Scale) −0.050 .327
Lifetime prevalence of alcohol use disorder (yes/no) 11.9 (±8.4)/9.7 (±7.4) .037d
Lifetime prevalence of substance use disorder (yes/no) 10.5 (±7.6)/10.2 (±7.7) .497d
Lifetime prevalence of any impulse control disorder (yes/no) 10.4 (±7.9)/10.2 (±7.7) .942d
Current smoking (yes/no) 10.9 (±8.5)/9.5 (±6.7) .161
Previous formalized treatmente for GD (yes/no) [Nf= 365] 9.6 (±8.1)/10.1 (±7.9) .665
Previous gamblers anonymous treatment [N= 365] 10.3 (±8.6)/9.8 (±7.5) .657
First-degree relative with history of GD (yes/no) 10.9 (±7.9)/9.8 (±7.6) .057
First-degree relative with history of AUD (yes/no) 11.2 (±8.0)/8.9 (±7.1) .001
Quality of life (QOLIg) [N= 134] −0.170 .049
Neurocognitive variablesh
Response inhibition (delay at the stop-signal task) [N= 77] 0.100 .388
Cognitive ﬂexibility (intra-/extra-dimensional set shifting test) [N= 77] −0.019 .873
Note. p values with statistically signiﬁcant differences (p< .05) are highlighted in bold.
aDuration of illness was deﬁned as the difference between [age at intake] and [age at onset of gambling disorder]. bStandard deviation.
cSpearman’s rank correlation coefﬁcient. dp values adjusted for age. eFormalized treatment: individual outpatient treatment and/or group
outpatient treatment and/or inpatient treatment. fNumber of valid subjects for the variable. If N is not displayed, the total sample (n= 448) was
evaluated for the variable. gQuality of Life Inventory (Frisch et al., 1992). hThe following measures were used: [delay at the stop-signal
task]= stop-signal reaction time (ms); [intra-/extra-dimensional set shifting test]= total errors (adjusted).
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et al., 2003). Therefore, gender differences in DOI may
cause this discrepancy. However, this study did not ﬁnd
statistically signiﬁcant differences between men and women
in terms of DOI nor lag between ﬁrst gambling and GD
[mean DOI: men = 11.1 (±8.8) years, women = 9.6 (±6.7)
years, sig. = .250; mean lag between ﬁrst gambling and GD:
men = 10.1 (±10.6) years, women = 8.8 (±9.7) years, sig.
= .309). In this context, it is unlikely that the differences
observed in the progression to GD in the current research is
a consequence of gender-associated issues.
A faster progression from recreational gambling to GD
appears to be associated with higher severity. For example,
we found a negative correlation between lag from ﬁrst
gambling to GD and severity of gambling behavior in
accordance with PG-YBOCS (Spearman’s rank correlation
coefﬁcient=−0.155; sig.= .009) and G-SAS (Spearman’s
rank correlation coefﬁcient=−0.245; sig. < .001). Further-
more, lag from ﬁrst gambling to GDwas positively correlated
with QOLI (Spearman’s rank correlation coefﬁcient= 0.301;
sig.= .001).
These ﬁndings are consistent with what Blaszczynski and
Nower (2002) describe as the “impulsive gambler.” Impul-
sive gamblers show more severe gambling levels, more
impact in non-gambling-related areas, earlier onset, and
unresponsiveness to treatment. Therefore, they are less
likely to recover and more prone to present longer DOI.
In the clinical setting, patients with longer DOI and faster
progression from recreational gambling to GD may beneﬁt
from long-term customized psychotherapeutic interventions
focused on impulse control (Blaszczynski & Nower, 2002).
Personal history of AUD and family history of AUD and GD
The subjects with lifetime AUD showed a signiﬁcantly
longer DOI when compared with those without the history
of AUD. The family history of AUD was also correlated
with a more extended DOI. In addition, the participants
with family history of GD showed a trend to present longer
DOI.
The association between longer DOI and AUD may
possibly represent two underlying processes. The ﬁrst ele-
ment appears to be a common genetic vulnerability between
GD and AUD. Shaffer et al. (1999) suggested that AUD was
associated with an increased risk of developing GD. Accord-
ingly, Slutske et al. (2000) investigated twins and found that
there is a common genetic susceptibility for GD and AUD.
Recent research has shown that GD and AUD addictions
share signiﬁcant similarities, such as continuous behavior
despite relevant negative consequences, development of
tolerance/withdrawal symptoms, presence of urges/craving,
neurocognitive ﬁndings, and a chronic course (Bechara,
2001; Blanco et al., 2001; Potenza, 2001, 2008).
The second possible factor is a behavioral interaction
between AUD and gambling. Alcohol use is associated with
greater impulsivity (Dougherty, Marsh-Richard, Hatzis,
Nouvion, & Mathias, 2008) and risky behaviors, such as
risky sex, irresponsible driving, and gambling (Cooper,
2002; McCarthy, Niculete, Treloar, Morris, & Bartholow,
2012). Therefore, subjects who use alcohol may also be
prone to gamble or bet more due to behavioral disinhibition
when intoxicated. As a result, co-occurring AUD may
facilitate relapse and lead to a more chronic course. In this
context, assessing and managing AUD is an important step
in the treatment of GD.
Proper treatment of AUD may reduce the DOI and avoid
further negative consequences.
DOI and quality of life
As expected, this study observed a negative correlation
between DOI and quality of life. GD is correlated with a
wide range of negative consequences, such as legal, rela-
tional, ﬁnancial, and occupational problems (Grant & Kim,
2005; Petry & Kiluk, 2002; Petry et al., 2005). As a result,
individuals with chronic GD tend to suffer adverse impacts
for a longer period and this in turn may ultimately affect the
quality of life.
This is worrisome since disordered gamblers overall
(regardless of DOI) tend to have a lower quality of life
when compared with the general population (Black et al.,
2003). In our sample, the mean [33.2 (±13.8)] and median
(34.0) QOLI were in the very low range (QOLI scores of 37
or less) (Frisch, 2009). In this context, the chronic disor-
dered gamblers tend to present an even lower quality of life.
Regarding treatment-seeking behavior, only 18.6% of the
subjects in this study had sought formalized treatment spe-
ciﬁcally for GD. This percentage is consistent with the
previous literature which suggests that the vast majority of
individuals with gambling problems do not seek treatment
(Slutske, 2006). Embarrassment and negation of the problem
seem to be important explanatory factors (Suurvali, Cording-
ley, Hodgins, & Cunningham, 2009). Therefore, appropriate
training of health professionals regarding GD, motivational
interviewing, and stigma may increase the treatment-seeking
behavior. As psychological and pharmacological interven-
tions may provide signiﬁcant beneﬁts (Dell’Osso, Allen, &
Hollander, 2005; Pallesen, Mitsem, Kvale, Johnsen, &
Molde, 2005), strategies to increase adequate care of disor-
dered gamblers may improve their quality of life.
Limitations and future studies
This study has signiﬁcant strengths such as: (a) the investi-
gation of an important and understudied clinical variable in
the treatment of disordered gambling (DOI); (b) the use of a
large sample (n= 483); and (c) a comprehensive evaluation
including gold-standard measures on psychiatric symptoms,
co-occurring disorders, overall functioning, and neurocog-
nitive variables. However, this study presents some limita-
tions. First, this is a cross-sectional research, and although
it provides measures of association, causal conclusions
cannot be inferred. It is important to replicate and further
understand our ﬁndings in other study designs such as
longitudinal studies. Second, this study used subjects who
participated in clinical trials. Therefore, caution is needed
when generalizing our ﬁndings to other patient populations.
Third, some of the data in this research (such as [age of ﬁrst
gambling], [age at onset of GD], and [money lost last year])
were retrospectively evaluated. Consequently, it is possible
that these assessments had some degree of recall bias.
Despite the limitations, this study presents an innovative
approach to GD and provides an important insight on a
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clinically relevant and understudied topic. Longitudinal
research approaching clearer causal associations and the
biological changes associated with different DOI is needed.
It will be particularly interesting to investigate the possible
biological changes associated with different DOI. It is
important not only to further study treatment-seeking sam-
ples but also to expand research on DOI to non-treatment-
seeking samples.
CONCLUSIONS
This study suggests that some important variables are
associated with different DOI. DOI was negatively corre-
lated with a lag from recreational gambling to GD (in years).
In addition, the subjects with lifetime history of AUD and
family history of AUD demonstrated a longer DOI. Finally,
there was a negative correlation between DOI and quality of
life. Increasing treatment-seeking behavior, providing cus-
tomized psychological interventions, and effectively man-
aging AUD may decrease the high levels of chronicity in
GD. Furthermore, research on GD such as phenomenologi-
cal studies and clinical trials may consider the duration of
GD in their methodology. DOI might be an important
variable when analyzing treatment outcome and avoiding
confounders.
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